COVID-19 Vaccine Janssen: Risk of Thrombosis in combination with Thrombocytopenia

COVID-19 Vaccine Janssen: Risk of Thrombosis in combination with Thrombocytopenia

Janssen Pharmaceutica (Pty) Ltd, as directed by the South African Health Products Regulatory Authority (SAHPRA) would like to inform you about the risk of thrombosis in combination with thrombocytopenia, associated with the use of COVID-19 Vaccine Janssen

2021 Nov

Download latest version
File Type: pdf
Category: Communication To Health Care Professionals
Unit: pharmacovigilance